VINORELBINE AND DOCETAXEL COMBINATION AS FIRST LINE TREATMENT IN PATIENTS WITH METASTATIC BREAST CANCER - RESULTS OF A MULTICENTRIC PHASE II TRIAL IN IRAN

被引：0
|
作者：
Ameri, A. [1 ]
Shahrad, B. [1 ]
Madani, H. [1 ]
Fazlalizadeh, A. [1 ]
Mousavizadeh, A. [1 ]
机构：
[1] Shahid Beheshti Univ Med Sci, Imam Hossein Hosp, Tehran, Iran
来源：
ANNALS OF ONCOLOGY | 2010年 / 21卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：119 / 119
页数：1
相关论文
共 50 条
  • [31] Docetaxel and epirubicin as first-line treatment for patients with metastatic breast cancer: A minnie pearl cancer research network phase II trial
    Hainsworth, John D.
    Yardley, Denise A.
    Spigel, David R.
    Meluch, Anthony A.
    Rinaldi, David
    Schnell, Frederick M.
    Greco, F. Anthony
    CANCER INVESTIGATION, 2006, 24 (05) : 469 - 473
  • [32] Phase II study of gefitinib in combination with docetaxel as first-line therapy in metastatic breast cancer
    Ciardiello, F.
    Troiani, T.
    Caputo, F.
    De Laurentiis, M.
    Tortora, G.
    Palmieri, G.
    De Vita, F.
    Diadema, M. R.
    Orditura, M.
    Colantuoni, G.
    Gridelli, C.
    Catalano, G.
    De Placido, S.
    Bianco, A. R.
    BRITISH JOURNAL OF CANCER, 2006, 94 (11) : 1604 - 1609
  • [33] Phase II study of gefitinib in combination with docetaxel as first-line therapy in metastatic breast cancer
    F Ciardiello
    T Troiani
    F Caputo
    M De Laurentiis
    G Tortora
    G Palmieri
    F De Vita
    M R Diadema
    M Orditura
    G Colantuoni
    C Gridelli
    G Catalano
    S De Placido
    A R Bianco
    British Journal of Cancer, 2006, 94 : 1604 - 1609
  • [34] A clinical phase II study of a non-anthracycline sequential combination of cisplatin-vinorelbine followed by docetaxel as first-line treatment in metastatic breast cancer
    Shamseddine, Ali I.
    Otrock, Zaher K.
    Khalifeh, Mohamad J.
    Yassine, Hanan R.
    Charafeddine, Maya
    Abdel-Khalek, Zeina
    Chehal, Aref
    Bitar, Nizar
    Jalloul, Rahif
    Dheiny, Moussa
    Dandashi, Azzam
    Wehbeh, Mahmoud
    El-Saghir, Nagi S.
    ONCOLOGY, 2006, 70 (05) : 330 - 338
  • [35] Weekly docetaxel and gemcitabine as first-line treatment for metastatic breast cancer:: Results of a multicenter phase II study
    Palmeri, S
    Vaglica, M
    Spada, S
    Filippelli, G
    Farris, A
    Palmeri, L
    Massidda, B
    Misino, A
    Ferraù, F
    Comella, G
    Leonardi, V
    Condemi, G
    Mangiameli, A
    De Cataldis, G
    Macaluso, MC
    Cajozzoo, M
    Iannitto, E
    Danova, M
    ONCOLOGY, 2005, 68 (4-6) : 438 - 445
  • [36] Phase I/II study of biweekly vinorelbine and oxaliplatin as first-line treatment in patients with metastatic breast cancer
    Guerrero, Antonio
    Servitja, Sonia
    Rodriguez-Lescure, Alvaro
    Calvo, Lourdes
    del Barco, Sonia
    Teresa Quintanar, Maria
    Ignacio Juarez, Jose
    Gayo, Javier
    Llombart, Antonio
    Tusquets, Ignasi
    ANTI-CANCER DRUGS, 2011, 22 (03) : 283 - 289
  • [37] Treatment of metastatic breast cancer with vinorelbine and docetaxel
    Savio, Giuseppina
    Laudani, Agata
    Leonardi, Vita
    Pepe, Alessio
    Scianna, Caterina
    Gebbia, Vittorio
    Agostara, Biagio
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2006, 29 (03): : 276 - 280
  • [38] Phase II study of vinorelbine and capecitabine as first-line treatment for metastatic breast cancer.
    El-Sadda, Wael
    Halim, Inas Ibraheim Abdel
    Aziz, Mohamed Abdel
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [39] Phase II trial of gefitinib combined with docetaxel as first-line therapy in patients with metastatic breast cancer.
    Ciardiello, F
    Troiani, T
    Caputo, F
    de Laurentiis, M
    Tortora, G
    Palmieri, G
    de Vita, F
    Colantuoni, G
    de Placido, S
    Bianco, AR
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 211S - 211S
  • [40] A Phase II Trial of Vinflunine As Monotherapy or in Combination with Trastuzumab as First-Line Treatment of Metastatic Breast Cancer
    Yardley, Denise A.
    McCleod, Michael
    Schreiber, Fred
    Murphy, Patrick
    Patton, Jeffrey
    Thompson, Dana S.
    Shastry, Mythili
    Rubin, Mark
    Melnik, Marianne
    Burris, Howard A.
    Hainsworth, John D.
    CANCER INVESTIGATION, 2010, 28 (09) : 925 - 931
12345